FDG-PET Patterns Predict Amyloid Deposition and Clinical Profile in Corticobasal Syndrome

被引:30
作者
Parmera, Jacy Bezerra [1 ]
Coutinho, Artur Martins [2 ]
Aranha, Mateus Rozalem [2 ,3 ]
Studart-Neto, Adalberto [1 ]
de Godoi Carneiro, Camila [2 ]
de Almeida, Isabel Junqueira [4 ]
Fontoura Solla, Davi J. [5 ]
Ono, Carla Rachel [2 ]
Barbosa, Egberto Reis [1 ]
Nitrini, Ricardo [1 ]
Buchpiguel, Carlos Alberto [2 ]
Brucki, Sonia Maria Dozzi [1 ]
机构
[1] Univ Sao Paulo HC FMUSP, Fac Med, Hosp Clin, Dept Neurol, Sao Paulo, Brazil
[2] Univ Sao Paulo HC FMUSP, Fac Med, Hosp Clin, Lab Nucl Med LIM 43,Ctr Nucl Med,Inst Radiol, Sao Paulo, Brazil
[3] Univ Sao Paulo HC FMUSP, Fac Med, Hosp Clin, Inst Radiol,Lab Magnet Resonance Neuroradiol LIM, Sao Paulo, Brazil
[4] Univ Sao Paulo HC FMUSP, Fac Med, Hosp Clin, Dept Phys Therapy Speech & Occupat Therapy, Sao Paulo, Brazil
[5] Univ Sao Paulo HC FMUSP, Fac Med, Hosp Clin, Dept Neurol,Div Neurosurg, Sao Paulo, Brazil
基金
巴西圣保罗研究基金会;
关键词
corticobasal syndrome; corticobasal degeneration; positron emission tomography; F-18]fluorodeoxyglucose; amyloid PET; PROGRESSIVE SUPRANUCLEAR PALSY; ALZHEIMERS-DISEASE; DIFFERENTIAL-DIAGNOSIS; F-18-FDG PET; DEGENERATION; SCALE;
D O I
10.1002/mds.28373
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background Corticobasal syndrome (CBS) is an atypical parkinsonian syndrome related to multiple underlying pathologies. Objective To investigate if individual brain [F-18]fluorodeoxyglucose-positron emission tomography (FDG-PET) patterns could distinguish CBS due to Alzheimer's disease (AD) from other pathologies based on [C-11]Pittsburgh Compound-B (PIB)-PET. Methods Forty-five patients with probable CBS were prospectively evaluated regarding cognitive and movement disorders profile. They underwent FDG-PET and were distributed into groups: likely related to AD (CBS FDG-AD) or likely non-AD (CBS FDG-nonAD) pathology. Thirty patients underwent PIB-PET on a hybrid PET-magnetic resonance imaging equipment to assess their amyloid status. FDG and PIB-PET images were classified individually based on visual and semi-quantitative analysis, blinded to each other. Quantitative group analyses were also performed. Results CBS FDG-AD group demonstrated worse cognitive performances, mostly concerning attention, memory, visuospatial domains, and displayed more myoclonus and hallucinations. The non-AD metabolic group presented more often limb dystonia, ocular motor dysfunction, motor perseveration, and dysarthria. All patients classified as CBS FDG-AD tested positive at PIB-PET compared to 3 of 20 in the non-AD group. The individual FDG-PET classification demonstrated 76.92% of sensitivity, 100% of specificity and positive predictive value and 88.5% of balanced accuracy to detect positive PIB-PET scans. Individuals with positive and negative PIB-PET showed hypometabolism in posterior temporoparietal areas and in thalamus and brainstem, respectively, mainly contralateral to most affected side, disclosing possible metabolic signatures of CBS variants. Conclusion FDG-PET was useful to predict AD and non-AD CBS variants depicting their specific degeneration patterns, different clinical features, and brain amyloid deposition. (c) 2020 International Parkinson and Movement Disorder Society
引用
收藏
页码:651 / 661
页数:11
相关论文
共 50 条
[11]   Alzheimer's disease presenting as corticobasal syndrome [J].
Chand, Pratap ;
Grafman, Jordan ;
Dickson, Dennis ;
Ishizawa, Keisuke ;
Litvan, Irene .
MOVEMENT DISORDERS, 2006, 21 (11) :2018-2022
[12]  
Coutinho AM, 2020, EUR J NUCL MED MOL I, V47, P2666, DOI 10.1007/s00259-020-04714-0
[13]   The neuropsychiatric inventory: Assessing psychopathology in dementia patients [J].
Cummings, JL .
NEUROLOGY, 1997, 48 (05) :S10-S16
[14]   A Standardized [18F]-FDG-PET Template for Spatial Normalization in Statistical Parametric Mapping of Dementia [J].
Della Rosa, Pasquale Anthony ;
Cerami, Chiara ;
Gallivanone, Francesca ;
Prestia, Annapaola ;
Caroli, Anna ;
Castiglioni, Isabella ;
Gilardi, Maria Carla ;
Frisoni, Giovanni ;
Friston, Karl ;
Ashburner, John ;
Perani, Daniela .
NEUROINFORMATICS, 2014, 12 (04) :575-593
[15]   The phenotypical core of Alzheimer's disease-related and nonrelated variants of the corticobasal syndrome: A systematic clinical, neuropsychological, imaging, and biomarker study [J].
Di Stefano, Francesca ;
Kas, Aurelie ;
Habert, Marie-Odile ;
Decazes, Pierre ;
Lamari, Foudil ;
Lista, Simone ;
Hampel, Harald ;
Teichmann, Marc .
ALZHEIMERS & DEMENTIA, 2016, 12 (07) :786-795
[16]   Cerebral metabolic changes accompanying conversion of mild cognitive impairment into Alzheimer's disease: a PET follow-up study [J].
Drzezga, A ;
Lautenschlager, N ;
Siebner, H ;
Riemenschneider, M ;
Willoch, F ;
Minoshima, S ;
Schwaiger, M ;
Kurz, A .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2003, 30 (08) :1104-1113
[17]   FDG PET in the differential diagnosis of parkinsonian disorders [J].
Eckert, T ;
Barnes, A ;
Dhawan, V ;
Frucht, S ;
Gordon, MF ;
Feigin, AS ;
Eidelberg, D .
NEUROIMAGE, 2005, 26 (03) :912-921
[18]  
FAZEKAS F, 1989, J NUCL MED, V30, P1607
[19]   Movement disorder society task force report on the Hoehn and Yahr staging scale: Status and recommendations [J].
Goetz, CG ;
Poewe, W ;
Rascol, O ;
Sampaio, C ;
Stebbins, GT ;
Counsell, C ;
Giladi, N ;
Holloway, RG ;
Moore, CG ;
Wenning, GK ;
Yahr, MD ;
Seidl, L .
MOVEMENT DISORDERS, 2004, 19 (09) :1020-1028
[20]   [18F]FDG-PET is superior to [123I]IBZM-SPECT for the differential diagnosis of parkinsonism [J].
Hellwig, Sabine ;
Amtage, Florian ;
Kreft, Annabelle ;
Buchert, Ralph ;
Winz, Oliver H. ;
Vach, Werner ;
Spehl, Timo S. ;
Rijntjes, Michel ;
Hellwig, Bernhard ;
Weiller, Cornelius ;
Winkler, Christian ;
Weber, Wolfgang A. ;
Tuescher, Oliver ;
Meyer, Philipp T. .
NEUROLOGY, 2012, 79 (13) :1314-1322